These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 9653875

  • 21. Persistent reduction of cocaine seeking by pharmacological manipulation of adenosine A1 and A 2A receptors during extinction training in rats.
    O'Neill CE, Hobson BD, Levis SC, Bachtell RK.
    Psychopharmacology (Berl); 2014 Aug; 231(16):3179-88. PubMed ID: 24562064
    [Abstract] [Full Text] [Related]

  • 22. Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine.
    Depoortere R, Perrault G, Sanger DJ.
    Psychopharmacology (Berl); 1996 Apr; 124(3):231-40. PubMed ID: 8740044
    [Abstract] [Full Text] [Related]

  • 23. Blockade of the serotonergic system counteracts the dizocilpine-induced changes in dopaminergic function.
    Dall'Olio R, Gandolfi O, Gaggi R.
    Behav Pharmacol; 2000 Feb; 11(1):29-36. PubMed ID: 10821206
    [Abstract] [Full Text] [Related]

  • 24. Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.
    Schindler CW, Karcz-Kubicha M, Thorndike EB, Müller CE, Tella SR, Ferré S, Goldberg SR.
    Br J Pharmacol; 2005 Mar; 144(5):642-50. PubMed ID: 15678095
    [Abstract] [Full Text] [Related]

  • 25. Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.
    Karcz-Kubicha M, Antoniou K, Terasmaa A, Quarta D, Solinas M, Justinova Z, Pezzola A, Reggio R, Müller CE, Fuxe K, Goldberg SR, Popoli P, Ferré S.
    Neuropsychopharmacology; 2003 Jul; 28(7):1281-91. PubMed ID: 12700682
    [Abstract] [Full Text] [Related]

  • 26. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
    Berridge KC, Aldridge JW.
    Synapse; 2000 Sep 01; 37(3):194-204. PubMed ID: 10881041
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Adenosine A2 receptor regulation of apomorphine-induced turning in rats with unilateral striatal dopamine denervation.
    Vellucci SV, Sirinathsinghji DJ, Richardson PJ.
    Psychopharmacology (Berl); 1993 Sep 01; 111(3):383-8. PubMed ID: 7870978
    [Abstract] [Full Text] [Related]

  • 29. An automated method for the assessment of spontaneous and stereotyped climbing behavior in mice. Effects of the selective D1- and D2-dopamine receptor agonists SKF-38393 and RU-24926 and their association.
    Simon P, Charpentier S, Costentin J.
    Methods Find Exp Clin Pharmacol; 1991 Mar 01; 13(2):99-104. PubMed ID: 1830125
    [Abstract] [Full Text] [Related]

  • 30. Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats.
    Longoni R, Spina L, Di Chiara G.
    Life Sci; 1987 Nov 02; 41(18):2135-45. PubMed ID: 2959833
    [Abstract] [Full Text] [Related]

  • 31. Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents.
    Popoli P, Giménez-Llort L, Pezzola A, Reggio R, Martínez E, Fuxe K, Ferré S.
    Neurosci Lett; 1996 Nov 08; 218(3):209-13. PubMed ID: 8945765
    [Abstract] [Full Text] [Related]

  • 32. Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats.
    Morelli M, Pinna A, Wardas J, Di Chiara G.
    Neuroscience; 1995 Jul 08; 67(1):49-55. PubMed ID: 7477908
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies.
    Ferrer B, Gorriti MA, Palomino A, Gornemann I, de Diego Y, Bermudez-Silva FJ, Bilbao A, Fernandez-Espejo E, Moratalla R, Navarro M, Rodríguez de Fonseca F.
    Eur J Pharmacol; 2007 Mar 22; 559(2-3):180-3. PubMed ID: 17291487
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia.
    Kafka SH, Corbett R.
    Eur J Pharmacol; 1996 Jan 11; 295(2-3):147-54. PubMed ID: 8720578
    [Abstract] [Full Text] [Related]

  • 38. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
    Garrett BE, Holtzman SG.
    Eur J Pharmacol; 1994 Sep 01; 262(1-2):65-75. PubMed ID: 7813580
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.